
Edwards Lifesciences Corporation (NYSE:EW) reported better-than-expected second-quarter financial results on Thursday.
Edwards Lifesciences posted adjusted earnings of 67 cents per share, beating market estimates of 62 cents per share. The company's quarterly sales came in at $1.532 billion versus expectations of $1.488 billion.